Maria Rosa Motta

Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.

G. Rosti, C. Tassi, R. Conte, 1998, Haematologica.

High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma

E. Zamagni, S. Tura, M. Cavo, 1998, Bone Marrow Transplantation.

Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase

G. Rosti, S. Tura, N. Testoni, 1998, Bone Marrow Transplantation.

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.

G. Martinelli, R. Conte, S. Tura, 1996, Blood.

Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure

E. Zamagni, S. Tura, P. Tosi, 2000, Leukemia.

The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF

M. Baccarani, H. Agis, A. Curti, 2011, Bone Marrow Transplantation.